Chiltern International Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Wilmington NC United States (1982)
Status: Acquired by LabCorp (2017)

Organization Overview

First Clinical Trial
2005
NCT01082471
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chiltern Clinical Research Unit (CCRU). | Chiltern (Early Phase) Limited | Chiltern International Inc. | Chiltern International Ltd. | Chiltern Pesquisa Clinica Ltda | Europe Chiltern International Ltd, Berkshire, UK